F
Fusion Pharmaceuticals
Targeted alpha therapeutics (TAT) for the treatment of chemotherapy resistant cancers
About Fusion Pharmaceuticals
Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing next-generation precision medicines for cancer treatment. The company operates in the biopharmaceutical market, focusing on creating innovative radiotherapeutics that target multiple tumor types. Fusion Pharmaceuticals serves cancer patients and healthcare providers, aiming to improve patient outcomes and quality of life. The business model revolves around research and development, leveraging proprietary linker technology to enhance the safety and efficacy of their treatments. Revenue is generated through partnerships, licensing agreements, and eventual commercialization of their therapeutic products. The company is a spin-out from the Centre for Probe Development and Commercialization (CPDC), which provides it with a robust supply chain and extensive expertise in manufacturing. Fusion Pharmaceuticals is committed to pushing the boundaries of science to offer revolutionary cancer treatments.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2020
News
Open roles
Fusion Pharmaceuticals in the Hamilton ecosystem
The Fusion Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
FACIT (Fight Against Cancer Innovation Trust)
Series A12 investors entered at this stage
Johnson & Johnson Development Corporation
Johnson & Johnson Innovation
TPG Biotech
Genesys Capital
HealthCap
Varian Medical Systems
Adams Street Partners
Seroba Life Sciences
OrbiMed
Pivotal Life Sciences
Rock Springs Capital
Perceptive Advisors
Series B and later6 investors entered at this stage
Perceptive Advisors- RCRock Springs Capital
- PSPivotal Life Sciences
- MUMcMaster University
OrbiMed- CCCentre For Probe Development And Commercialization
Source: Dealroom Talent Intelligence.
See Fusion Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


